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MigrationMechanisms mediating closure of the dorsal vertebrae are not clear. Previously, we showed that deletion of
TGFβ type II receptor (Tgfbr2) in sclerotome in mice results in failure in the formation of the spinous pro-
cess, mimicking spina biﬁda occulta, a common malformation in humans. In this study, we aimed to deter-
mine whether missing dorsal structures in Tgfbr2 mutant mice were due to defects in mesenchymal
migration and to clarify mechanism of TGFβ-mediated migration. First, we showed that gross alterations
in dorsal vertebrae were apparent by E16.5 days in Tgfbr2 mutants. In addition, histological staining showed
that the mesenchyme adjacent to the developing cartilage was thin compared to controls likely due to re-
duced proliferation and migration of these cells. Next, we used a chemotaxis migration assay to show that
TGFβ promotes migration in mixed cultures of embryonic sclerotome and associated mesenchyme. TGFβ
stimulated expression of PDGF ligands and receptors in the cultures and intact PDGF signaling was required
for TGFβ-mediated migration. Since PDGF ligands are expressed in the sclerotome-derived cartilage where
Tgfbr2 is deleted and the receptors are predominantly expressed in the adjacent mesenchyme, we propose
that TGFβ acts on the sclerotome to regulate expression of PDGF ligands, which then act on the associated
mesenchyme in a paracrine fashion to mediate proliferation, migration and subsequent differentiation of
the adjacent sclerotome.
© 2012 Elsevier Inc. All rights reserved.Introduction
In vertebrates, the axial skeleton is composed of cartilage and
bone produced by paraxial mesoderm. The vertebral column is the
central part of the axial skeleton, and it includes the vertebral body,
the neural arch, and the intervertebral discs between adjacent verte-
bral bodies. During development, the paraxial mesoderm gives rise to
the segmental units of the somite. The somites then subdivide into
the dorsal dermomyotome and the ventral sclerotome under the in-
duction of signals from the notochord and the ﬂoor plate of the neural
tube (Pourquie et al., 1993). Sclerotome, a population of undifferen-
tiated mesenchymal cells, differentiate to form three subcompart-
ments: ventral, lateral, and dorsal, with each giving rise to distinct
parts of the vertebrae and ribs (Christ et al., 2000). Following a pro-
cess of patterned anterior–posterior fusion of consecutive sclero-
tomes, the vertebrae forms as a cartilaginous template that is later
converted into bone by endochondral ossiﬁcation.
Spina biﬁda (SB), or failure of the neural tube and vertebrae to
close at the midline, is one of the most common (1–2 cases per
1000 births) congenital malformations in humans leading to infant
mortality or severe disability. This condition is divided into four cate-
gories with spina biﬁda occulta (SBO) as the mildest form that onlyMCLM 660, Birmingham, AL
rights reserved.involves the vertebrae. As with many other problems, SB appears to
result from a combination of genetic and environmental risk factors,
but the major cause of SB is believed to be failure of neural tube clo-
sure during the ﬁrst 4 weeks of embryogenesis. However, accumulat-
ing evidence suggests that SB can result from defects in the somatic
mesoderm surrounding the neural tube (Furumoto et al., 1999;
Payne et al., 1997; Pickett et al., 2008; Stottmann et al., 2006).
The transforming growth factor beta (TGFβ) superfamily contains
signaling molecules that regulate many aspects of cell physiology in-
cluding skeletal development. TGFβ signals through a dual receptor
system of type I and type II transmembrane serine/threonine kinases
(Janssens et al., 2005). Upon TGFβ binding to type II receptor
(TGFbR2), which is a constitutively active kinase, type I receptor
(TGFbR1) can be recruited and becomes phosphorylated and activat-
ed. The canonical Tgfbr2 signaling pathway is mediated by a group of
transcription factors called Smads. Smads directly regulate the tran-
scription of target genes (Janssens et al., 2005). The role of members
of the TGFβ superfamily in speciﬁc aspects of skeletal development
and pathology is most clearly illustrated in mice and humans with
mutations or targeted deletions in their respective genes (Kingsley,
1994; Serra and Chang, 2003). Targeted deletion of the mouse Tgfb2
gene results in several skeletal abnormalities including failure in the
dorsal closure of the neural arches suggesting an important role for
the TGFβ2 ligand in vertebrae development (Sanford et al., 1997). Lit-
tle is known about the mechanisms of neural arch closure or of TGFβ
action in this process.
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chemotactic factor for cells of mesenchymal origin, including chon-
drocytes andmesenchymal stem cells. The PDGF signaling family con-
sists of four different polypeptide chains, designated A, B, C and D, as
well as two receptors α (PDGFRα) and β (PDGFR β). The four PDGF
chains assemble into ﬁve different dimeric isoforms: PDGF-AA,
PDGF-BB, PDGF-AB, PDGF-CC and PDGF-DD. PDGF-BB, AB and CC
can bind and activate both PDGFRα and β, whereas PDGF-AA binds
only PDGFRα (Bornfeldt et al., 1995). Upon binding to the receptor,
PDGF ligands transduce signals to regulate many biological functions
of cells, including proliferation, migration, differentiation, and apo-
ptosis (Heldin and Westermark, 1999). The PDGF ligand–receptor
system has also been implicated to play roles in wound healing
(Barrientos et al., 2008), tendon and cartilage repair (Molloy et al.,
2003; Schmidt et al., 2006), atherosclerosis (Ross, 1993), and tumor-
igenesis (Sun et al., 2005). A recent study showed that the PDGFRα
pathway plays a central role in regulating formation of the spinous
process (Pickett et al., 2008). Disruption of PDGFRα signaling in the
mesenchyme surrounding sclerotome-derived cartilage led to SBO
whereas disruption in the sclerotome itself had no effect on vertebral
development (Pickett et al., 2008). Since PDGF ligands were shown to
be expressed in sclerotome derived tissues and the receptors were
expressed in the surrounding mesenchyme, it was suggested that
paracrine signaling between the sclerotome and surrounding mesen-
chyme is required for closure of the neural arches and formation of
the spinous process (Pickett et al., 2008). Deletion of Pdgfc in mice
also resulted in SBO and it was suggested that PDGF-C acts through
PDGFRα to mediate development of the vertebrae (Ding et al.,
2004). TGFβ induces the expression of PDGF ligands in many cell
types, such as mesangial cells (Haberstroh et al., 1993) and endothe-
lial cells (Taylor and Khachigian, 2000), suggesting that TGFβ might
mediate physiological and pathological processes by regulating
PDGF signaling. In fact, various studies have implicated PDGF acting
in concert with TGFβ in development of organ ﬁbrosis, including pul-
monary and hepatic ﬁbrosis (Trojanowska, 2008).
Our previous results showed that deletion of Tgfbr2 in Col2a
expressing tissue in mice resulted in alterations in the formation of
the vertebrae and intervertebral disc (IVD) (Bafﬁ et al., 2004). These
mice demonstrated small vertebrae and the spinous process failed
to form, mimicking SBO in humans. These results suggested that
TGFβ plays an important role in regulating embryonic development
of the axial skeleton; however, the mechanism of this action has not
been clariﬁed. In this study, we aimed to determine whether the
missing dorsal structures in Tgfbr2 mutant mice were due to defects
in proliferation and migration, and to further clarify the underlying
mechanism of migration mediated by TGFβ. We ﬁrst show that
TGFβ signaling is required for dorsal closure of vertebrae and forma-
tion of the spinous process, and that gross disruption to development
is evident by E16.5 days. We then used a chemotaxis migration assay
to show that TGFβ signaling promotes the migration of sclerotome-
associated mesenchyme, and that the downstream effects of PDGF
are required. We propose that TGFβ acts through PDGF in a paracrine
manner to regulate migration of the mesenchyme adjacent to the
sclerotome and subsequent formation of the spinous process.
Material and methods
Mice
All experiments were carried out with the approval of the UAB in-
stitutional animal care committee. The generation of Tgfbr2ﬂ/ﬂ mice
was previously described (Chytil et al., 2002). Col2a-Cre mice were
obtained from Jackson laboratories (Ovchinnikov et al., 2000). The
Rosa26/+ reporter strain was obtained from Jackson labs (Soriano.,
1999). Col2a-Cre mice were crossed to Tgfbr2ﬂ/ﬂ mice to obtain
Col2a-Cre+;Tgfbr2ﬂ/wt mice, which were subsequently crossed toRosa26/Rosa26 mice to get the mice with a genotyping of
Col2aCre+;ROSA26/+;Tgfbr2ﬂ/wt. These mice were then used to back-
cross with Tgfbr2ﬂ/ﬂ to get Col2aCre+;ROSA26/+;Tgfbr2ﬂ/wt as controls
and Col2aCre+;ROSA26/+;Tgfbr2ﬂ/ﬂ as the experimental group.
Whole mount X-gal staining
Embryos were collected with the day of the vaginal plug designat-
ed as E0.5. Whole-mount X-gal staining was performed on the staged
embryos as described (Chai et al., 2000). Between ﬁve and ten embry-
os of each genotype were generated. Brieﬂy, embryos were taken and
skin was removed before the ﬁxation in 4% paraformaldehyde for 2 h
at room temperature. The ﬁxed embryos were soaked in the perme-
abilization solution for 1 h, followed by the staining solution over-
night at room temperature. Stained embryos were post-ﬁxed in 4%
paraformaldehyde overnight at 4 °C and then cleared with glycerol
for photography. Alterations in the dorsal most edge of the vertebra
were measured as the length of the gap between the edges of the
neural arches at the level of the second lumbar vertebrae in E15.5,
E16.5 and E17.5 day embryos. Measurements were taken from 5
mice of each genotype. Two embryos from each group were used
for sectioning. Frozen sections (10 μm) were prepared by embedding
the stained embryos in OCT (Tissue-Tek).
Histology, immunostaining, and cell proliferation
At least two E15.5, 16.5, and 17.5 day embryos from each group
were ﬁxed in 4% paraformaldehyde overnight, embedded in paraf-
ﬁn, and sectioned at 6 μm. For histological analysis, sections were
stained with either hematoxylin and eosin or alcian blue. For im-
munoﬂuorescence and immunohistochemical staining, sections
were de-waxed and hydrated, followed by antigen retrieval by boil-
ing the sections in citrate acid buffer (pH 6.0) for 20 min. After
blocking in 5% BSA for 1 h, the sections were incubated overnight
at 4 °C with a 1:100 dilution of primary antibodies. Antibodies
used for this experiment include Ki67 (NeoMarkers) and anti-
mouse PDGF-BB (Abcam). Biotinylated goat-anti-rabbit IgG or bioti-
nylated rabbit-anti-goat IgG (1:200, Vector lab) was added as the
secondary antibody. Fluorescent signal was detected with avidin-
conjugated Cy3, with DAPI as counterstain. Color was developed
with DAB (Vector laboratories), with hematoxylin as counterstain.
Proliferation of sclerotome and associated mesenchymal cells was
detected by immunostaining for Ki67 on deparafﬁnised sections as
described above. Ki67-positive cells and DAPI-stained total cells
were counted from ﬁve randomly selected boxed areas in the region
of neural arch. Percentage of proliferation was obtained by dividing
the number of Ki67-positive cells by the total number of cells. Data
were presented by multiplying 100. Signiﬁcance was determined
by T-test.
Micromass culture of sclerotome and associated mesenchyme
Sclerotome and associated mesenchyme ventral to the neural
tube were isolated from E11.5 day mouse embryos. The micromass
culture was set up using a method described previously (Sohn et
al., 2010). Brieﬂy, mesenchymal cells were dissociated into a single
cell suspension with incubation in 1 mg/ml collagenase D at 37 °C
for 30 min and reconstituted at a density of 1×107 cells/ml. Twenty
microliters of cell suspension was dropped into each well of a 24
well plate. After a pre-incubation time of 1 h at 37 °C to allow cells
to attach, the cultures were then ﬂooded with F-12:DMEM (1:1) con-
taining 10% FBS, 50 μg/ml ascorbic acid, 10 mM β-glycerolphosphate,
2 mM glutamine, antibiotics with or without different concentrations
of TGFβ1. For the cells infected with adenovirus, virus was added to
the cell drops with 2 μl per 20 μl drop (100 MOI, Multiplicity of
Infection).
Table 1
Primers used in real-time PCR.
Gene name Forward primer (5′–3′) Reverse primer (5′–3′)
Pdgfa TGTCAAGGTGGCCAAAGTGGAGTA TGCACACTCCAGGTGTTCCTCTAA
Pdgfb TGAAATGCTGAGCGACCACTCCAT AGTGTGCTCGGGTCATGTTCAAGT
Pdgfc AAGTTGAGGAGCCCAGTGATGGAA AAGGTACTGAAGGCAGTCACAGCA
β2-microglobulin GCCGTGTGAACCATGTGACTTT CCAAATGCGGCATCTTCAAA
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mRNA samples were collected from micromass cultures in which
cells were treated with either TGFβ1 (2.5, 5 ng/ml) for 8 h or Cre
virus (5, 10, 20 MOI) using the standard Trizol method (Paaske et
al., 1987). RNA concentration was determined by Nanodrop Spectro-
photometer. QuantiFast SYBR Green RT-PCR Kit (Qiagen) was used
for quantitative real-time RT-PCR analysis with speciﬁc primers
(Table 1). Data analysis was performed with REST software (Pfafﬂ
et al., 2002).
Chemotaxis cell migration assay
Cell migration was performed using 96-well chemotaxis chamber
as described (Pickett et al., 2008). Brieﬂy, sclerotome and associatedFig. 1. Disrupted formation of the dorsal vertebrae in Tgfbr2cko embryos.(A–C) Representative
E15.5, E16.5 and E17.5 days. Magniﬁcation: 25×. (D) Measurements of the gap between ne
lyzed by 2-way ANOVA; N=5; ***, Pb0.001 [E17.5 Cko vs E17.5 Con]; #, Pb0.05 [E17.5 Con v
from lumbar vertebrae of E17.5 control and Tgfbr2cko embryos. Dense mesenchyme dorsal t
staining of cryosections of the lumbar region from E15.5 control and Tgfbr2cko embryos. Den
dorsal edge of the neural arch in control mice (G, white arrow). This mesenchyme is reduc
stained E15.5 Col2aCre+;Rosa26/+ embryo. Cre activity is seen as blue X-gal stain in sclerot
enchyme. (J) Phase contrast image of I to show unstained adjacent mesenchyme. Magniﬁcamesenchymal cells were isolated as described above. Cells in single
cell suspension were stained with CellTracker™ Green CFDA or Red
CMPTX (5 μM) following the manufacture's protocol (Invitrogen).
Stained cells were then plated in triplicate at a density of 4×104
cells per well in a 96-well chemotaxis chamber (NeuroProbe), on a
ﬁlter (5 μm pore size, PVP-free) pre-treated for 1 h with 10 μg/ml
rat tail collagen (Sigma, St Louis, MO). Recombination proteins
were added to the bottom wells at the indicated concentrations.
TGFβ1, PDGF-AA and BB ligands were obtained from R&D Systems.
10% FBS was used as a positive control. Almost all the cells migrated
in response to FBS. AG1296 (25 μM, Sigma) treatment was 30 min
before plating cells in the chemotaxis chamber. The migration cham-
ber was incubated at 37 °C for 6 h. At the end of incubation, cells on
top of the ﬁlter were gently wiped off with a cotton swab. Cells on
the under-side of the ﬁlter were collected to the bottom of theimages of whole mount X-gal staining on control (Con) and Tgfbr2cko (Cko) embryos at
ural arches at the second lumbar region from E16.5 and E17.5 embryos. Data was ana-
s E16.5 Con]; +, Pb0.05 [E17.5 Cko vs E16.5 Cko]. (E, F) Alcian blue staining of sections
o the neural arch is seen in the control (white arrow). Magniﬁcation: 10×. (G, H) H & E
se mesenchyme adjacent to the sclerotome-derived cartilage is visible surrounding the
ed or absent in mutants (H, white arrow). Magniﬁcation: 20×. (I) Cryosection of X-gal
ome derived cells. Staining is not observed in the adjacent sclerotome-associated mes-
tion: 20×. c: cartilage; nt: neural tube; m: sclerotome associated mesenchyme.
Table 2
Percentage of cell proliferation in E15.5 and E17.5 day dorsal vertebrae.
Stage Cell type Control Tgfbr2cko P value
E15.5 Chondrocytes 75.0±4.38 80.9±2.58 0.10
Adjacent mesenchymal cells 82.8±4.54 73.4±1.86 0.02⁎
E17.5 Chondrocytes 84.8±2.51 86.6±4.08 0.56
Adjacent mesenchymal cells 66.7±3.54 59.8±3.93 0.08
Data are expressed as mean±SE, n=5 ﬁelds in 3 separate slides each.
⁎ Pb0.05.
Fig. 2. TGFβ regulates migration in sclerotome associated mesenchyme in culture.(A)
Sclerotome and associated mesenchyme was isolated from E11.5 Tgfbr2ﬂ/ﬂ embryos
and infected with adenovirus Cre (Ad-Cre) to delete Tgfbr2 or with adenovirus GFP
(Ad-GFP) as a control. Loss of Tgfbr2 resulted in reduced basal migration. ***,
Pb0.001. RT-PCR in the upper panel shows the deletion of the Tgfbr2 allele using Ad-
Cre, 100 MOI. (B) The migration assay was performed on sclerotome and associated
mesenchymal cells isolated from E11.5 wild type embryos and treated with or without
TGFβ in the bottom well. TGFβ stimulated migration. ***, Pb0.001. (C) Cells were isolat-
ed from Col2aCre+;Rosa26/+ mice and used in the migration assay with TGFβ in the
bottom well. Sclerotome derived cells were stained blue with X-gal, unstained cells
represent sclerotome associated cells. The total nonmigrated cell population demon-
strated both stained and unstained cells. Migrated cells at the bottom of the chamber
were not stained. Images were selected from several wells for both total and migrated
cells. Magniﬁcation: 40×.
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at 500 g. Cell migration was measured by reading the ﬂuorescence
in each well using a microplate reader (Synergy HT, BioTek). Each ex-
periment was performed at least twice, and each condition was
assayed in triplicate.
To determine which cells were migrating in the mixed sclerotome
and sclerotome- associated cell cultures, cells isolated from
Col2aCre+;ROSA26/+mice were used in the migration assay with
TGFβ in the bottom of the well. The sclerotome from each embryo
was individually held in Eppendorf tubes and placed on ice until the
genotyping was ﬁnished. Sclerotome from mice with the genotyping
of Col2aCre+;ROSA26/+ was pooled and single cell suspension was
obtained after digestion with Collagenase D (1 mg/ml, Roche) for
1 h at 37 °C. Some of the cells were used to perform the migration
assay as described above with TGFβ, and some cells were directly
plated on the bottom wells of the chemotaxis chamber at the density
of 4×104 cells per well to use as a control for staining in the total cell
population. At the end of the migration assay, cells on the under-side
of the ﬁlter were collected to the bottom of the microplate well by
centrifuging the microplate assembly for 10 min at 500 ×g. Cells (mi-
grated and control) were ﬁxed in the ﬁxative solution (2% formalde-
hyde/methanol, 0.1% glutaraldehyde in PBS) for 2 min at room
temperature. After 3 washes with PBS, the staining solution (1 mg/
ml of X-gal, 5 mM of potassium ferricyanide, 5 mM of potassium fer-
rocyanide, 2 mM of magnesium chloride) was added to each well. The
plate was incubated over night at 37 °C. Images were taken under the
light microscope. Three individual ﬁelds were taken for each well.
This experiment was performed three times.
In situ hybridization
E15.5 embryos were ﬁxed in 4% paraformaldehyde (PFA) over-
night at 4 °C then processed for OCT embedding and cryo-
sectioning. Probes for PDGFc were synthesized from cDNA, followed
by the cloning using pGEM-T Easy Vector System (Promega). The
templates were linearized by restriction enzymes NcoI or PstI follow-
ing themanufacture's protocol (NEB). DIG labelled probes were creat-
ed using T7/Sp6 DIG RNA Labeling Kit (Roche). The in situ
hybridization was performed following the method described previ-
ously (Sohn et al., 2010).
Results
TGFβ signaling regulates cell migration
Our previous results showed that deletion of Tgfbr2 in Col2a
expressing tissue in mice resulted in alterations in the formation of
the vertebrae and IVD (Bafﬁ et al., 2004). These mice demonstrated
small vertebrae and the spinous process failed to form mimicking
SBO in humans. To determine the timing and extent of the defect,
we marked the sclerotome with LacZ using a Cre-reporter line that
conditionally expresses LacZ in the presence of Cre by the excision of
a PGKneo cassette in front of the lacZ gene. Thus, cells that express
Cre can be stained blue with X-gal (Soriano, 1999). The dorsal most
edge of sclerotome derived tissue was compared in control
(Col2aCre+;ROSA26/+;Tgfbr2ﬂ/wt) and Tgfbr2cko (Col2aCre+;ROSA26/+;Tgfbr2ﬂ/ﬂ) embryos starting at E12.5 days. No differences were ob-
served at E12.5 or E15.5 days (not shown and Fig. 1A). Between
E16.5 and E17.5 the dorsal gap decreased in both control and Tgfbr2cko
embryos; however, the decrease in the gap size was less in Tgfbr2cko
embryos (Figs. 1B–D). At E17.5 days a signiﬁcant increase in the size
of the dorsal gap was seen in control versus Tgfbr2cko embryos (Figs.
1C, D). Alcian blue staining of sections from the lumbar vertebrae of
E17.5 embryos clearly showed the defective neural arch closure in
the Tgfbr2cko mice (Figs. 1E, F). In addition, the dense mesenchyme
normally adjacent to the dorsal part of the neural arch was thin or
missing as early as E15.5 days in Tgfbr2cko embryos (Figs. 1G, H,
white arrows), even though Cre was not directly active in these cells
(Figs. 1I, J)
To determine if the reduction in the mesenchyme adjacent to the
sclerotome-derived cartilage was due to alterations in proliferation,
we stained sections from E15.5 and E17.5 day embryos with Ki67 and
determined the percent of labelled nuclei in the cartilage and in the ad-
jacent mesenchyme (Table 2). Proliferation in sclerotome-derived
Table 3
Gene expression level tested by real-time PCR.
Gene name Treatment Fold change Standard error range
Pdgfa TGFβ1 2.5 ng/ml
5 ng/ml
0.885 0.647–1.201
0.812 0.587–1.110
Pdgfb TGFβ1 2.5 ng/ml
5 ng/ml
4.563 3.451–6.037
3.515 2.736–4.801
Pdgfc TGFβ1 2.5 ng/ml
5 ng/ml
2.908 2.569–3.326
2.417 2.186–2.676
Pdgfb Ad-Cre 5 MOI
10 MOI
20 MOI
0.678 0.484–0.884
0.645 0.586–0.703
0.617 0.261–0.981
Pdgfc Ad-Cre 5 MOI
10 MOI
20 MOI
0.586 0.533–0.666
0.433 0.379–0.487
0.291 0.147–0.445
Data are normalized by the reference gene β2-microglobulin. The TGFβ1 treated
groups are compared with the un-treated group for each gene, and the Ad-Cre treated
groups are compared with the Ad-GFP (10 MOI) treated group for each gene.
Fig. 3. PDGF ligands plays an important role in TGFβ mediated cell migration.(A) Cells
were isolated from wild type embryos and were either treated or not treated with
PDGF-AA or PDGF-BB at the bottom of the well. Both PDGF ligands stimulated cell mi-
gration. ***, Pb0.001. (B) Cells from wild type embryos were pre-treated with AG1296
(25 μM) for 30 min. before being placed in the migration assay with or without TGFβ in
the bottom well. DMSO is the solvent control. SFM is the serum free medium control.
TGFβ-stimulated migration was blocked by the PDGFR antagonist. ***, Pb0.001
[SFM+TGFβ1 vs SFM-TGFβ1]; ###, Pb0.001 [AG1296+TGFβ1 vs DMSO+TGFβ1]. (C)
Cells were isolated from Tgfbr2ﬂ/ﬂ embryos and infected with Ad-Cre to delete Tgfbr2
or with Ad-GFP as a control. The cells were placed in the migration assay with or without
PDGF-BB in the bottom well. PDGF-BB stimulated migration in Tgfbr2 deleted cells. ***,
Pb0.001 [Ad-Cre vs Ad-GFP]; #, Pb0.01[Ad-Cre+PDGF-BB 10 ng/ml vs Ad-Cre]. Representa-
tive of two separate experiments is shown.
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either stage, conﬁrming what we reported earlier for ventral vertebrae
and long bone cartilage (Bafﬁ et al., 2004, 2006). In contrast, prolifera-
tion in mesenchymal cells adjacent to the neural arch was signiﬁcantly
down-regulated in Tgfbr2 mutant mice at E 15.5 days (Table 2). Since
Cre is not active in the adjacent mesenchyme, the result suggests
that a paracrine interaction may be involved.
It was previously shown that migration of the mesenchyme adja-
cent to the sclerotome regulates closure of the neural arches (Pickett
et al., 2008). To test the hypothesis that TGFβ regulates migration, we
established an in vitro transwell chemotaxis assay using sclerotome
and associated mesenchymal cells from E11.5 embryos. We showed
that cells lacking Tgfbr2 via adenovirus Cre infection of cells isolated
from Tgfbr2ﬂ/ﬂ mice had impaired basal migration compared with
cells infected with adenovirus GFP as a control, suggesting that
TGFβ regulates a basal amount of migration in these cells (Fig. 2A).
Furthermore, wild type cells responded to exogenous TGFβ with in-
creased migration at the dosages of 2.5, 5, and 10 ng/ml (Fig. 2B).
The maximum response was observed at the concentration of
2.5 ng/ml. These data indicate that TGFβ regulates cell migration
and suggest that TGFβ-mediated migration may play an important
role in closure of the neural arches.
To determine which cells in the cultures, sclerotome-derived or
sclerotome-associated, were migrating in response to TGFβ, we
used cells isolated from Col2aCre+;Rosa26/+ mice in the migration
assay. In this way, Cre activity could be visualized by blue X-gal stain-
ing in sclerotome derived cells whereas sclerotome associated cells in
the culture would not express Cre and would not stain with X-gal. As
a control for staining in the total cell population, we plated some of
the isolated cells directly on the bottom wells of the migration cham-
ber. As expected, the total population of cells contained a mixture of
X-gal stained and unstained cells (15% X-gal stained); however, we
could not detect any X-gal staining in the cells that had migrated in
response to TGFβ (Fig. 2C). This result suggests that cells isolated
from E11.5 embryos are mixed populations containing sclerotome
and associated mesenchyme, and TGFβ induces migration of the
sclerotome associated mesenchymal cells.
PDGF plays an essential role in TGFβ-mediated cell migration
A recent study showed that PDGFRα plays a central role in regulat-
ing closure of the neural arches by promotingmigration of the mesen-
chymal cells adjacent to the sclerotome-derived cartilage through a
PI3K dependent mechanism (Pickett et al., 2008). It was also shown
that the PDGF receptor was expressed in the mesenchyme adjacent
to the sclerotome while the PDGF ligands were expressed in the carti-
lage derived sclerotome (Pickett et al., 2008). The phenotype observed
in the dorsal vertebrae in PdgfraPI3K/PI3K mice resembled that seen inthe Tgfbr2cko mice including failure of the spinous process to form
and reduced or thin mesenchyme adjacent to the cartilage. Since
PDGF ligands are regulated by TGFβ in other systems (Haberstroh et
al., 1993; Taylor and Khachigian, 2000), we looked at the expression
of PDGF ligands at the mRNA level in cultures of sclerotome and asso-
ciated mesenchyme treated with TGFβ. Relative levels of mRNA were
compared using quantitative real-time RT-PCR. Our results showed
that TGFβ up-regulated the expression of Pdgfb and Pdgfc, whereas
Pdgfa did not appear to be regulated (Table 3). We next assayed the
expression of Pdgfb and Pdgfc in cells that had been deleted for
Tgfbr2. Sclerotome and associated cells were isolated from Tgfbr2ﬂ/ﬂ
mice and infected with adenovirus Cre to delete Tgfbr2. In cells with
disrupted TGFβ signaling, expressions of Pdgfb and Pdgfc were de-
creased (Table 3), suggesting that PDGF ligands -B and/or -C could
be downstream effectors of TGFβ regulating cell migration. It should
be noted that both PDGF-B and PDGF-C can bind and activate PDGFRα
(Bornfeldt et al., 1995), suggesting that they could act as a link
115Y. Wang, R. Serra / Developmental Biology 365 (2012) 110–117between TGFβ signaling in the sclerotome and PDGFRα signaling in
the adjacent mesenchyme.
We next determined the direct effect of PDGF ligands on cell mi-
gration using the chemotaxis assay. In our experiment, PDGF-AA
and PDGF-BB both induced migration at distinct concentrations
(Fig. 3A). PDGF-AA activates PDGFRα and PDGF-BB can activate
PDGFRα and β. To determine whether PDGF signaling is required
for sclerotome migration, we blocked PDGF signaling by administer-
ing AG1296 to the cells prior to the chemotaxis assay. AG1296 is a
small molecule that selectively inhibits PDGF receptor kinase, thereby
blocking the action of PDGF ligands (Reiterer et al., 2008). Treatment
with the antagonist alone did not affect the basal level of migration in
the cells. However, cells in which PDGF signaling was blocked did not
respond to TGFβ1 as the untreated cells did (Fig. 3B), suggesting that
PDGF signaling is required for TGFβ-mediated cell migration. We
showed above that cells without Tgfbr2 have impaired migration
(Fig. 2A). Migration was restored in Tgfbr2 depleted cells by adding
exogenous PDGF-BB (Fig. 3C). Together, these data suggest that the
effects of TGFβ on migration are mediated by PDGF signaling.
PDGF-B and PDGF-C are reduced in Tgfbr2cko cartilage
Pickett et al. showed that PDGFRα is primarily expressed in peri-
chondrium and the dense mesenchyme adjacent to cartilage forming
sclerotome. Disruption of Pdgfra in sclerotome-derived cartilage using
Col2a-Cre had no effect on the closure of the vertebrae. However, em-
bryos lacking Pdgfrα in the adjacent mesenchyme developed SBO
(Pickett et al., 2008). In order to further determine the mechanism
for the phenotype observed in Tgfbr2cko mice, we performed immu-
nohistochemical staining for PDGF-B on sections of lumbar vertebrae
from control and Tgfbr2cko E15.5 embryos (Figs. 4A–C). PDGF-B wasFig. 4. PDGF-B and PDGF-C expression in Tgfbr2cko mice.(A–C) Immunostaining of PDGF-B
staining is seen as a brown DAB substrate. Negative control without primary antibody is sho
bridization to PdgfbmRNA in control (D, E) and Tgfbr2cko (F, G) cartilage (D, F) and dorsal ro
(J) cartilage. Digoxigenin labelled RNA hybridization is seen as a purple NBT/BCIP substrateexpressed in sclerotome-derived cartilage (Fig. 4A). In Tgfbr2cko em-
bryos, the expression of PDGF-B was reduced in the cartilage even
though expression in the dorsal root ganglion (DRG) was comparable
in control and Tgfbr2cko mice (Figs. 4A, B). PDGF-C protein was previ-
ously shown to be localized to sclerotome, myotome, and vertebral
cartilage (Aase et al., 2002). To determine if there were alterations
in the Pdgfb and Pdgfc gene expression, we used in situ hybridization
on transverse sections of E15.5 day control and Tgfbr2cko embryos.
Both Pdgfb (Figs. 4D–H) and Pdgfc mRNA (Figs. 4I–K) were limited
in the Tgfbr2cko cartilage relative to the controls. Expression of Pdgfb
mRNA was again comparable in control and Tgfbr2cko dorsal root gan-
glion (Figs. 4E, G). No signal was observed with the RNA sense strand
controls (Figs. 4H, K). We therefore propose that TGFβ-mediated al-
terations in expression of the PDGF ligands in cartilage may affect
PDGFRα signalling in the adjacent mesenchymal cells resulting in
failure in the formation of the spinous process.
Discussion
The previous study in our laboratory showed that deletion of
Tgfbr2 in Col2a expressing tissue in mice resulted in alterations in
the formation of the vertebrae and IVD (Bafﬁ et al., 2004). These
mice demonstrated small vertebrae and the spinous process failed
to form, mimicking SBO in humans. SB is one type of neural tube de-
fect in which the backbone and spinal canal do not close before birth.
SBO is the mildest and most common form of SB, a condition in which
the spinous process and neural arch appear abnormal on a radiogram,
but meninges remain in place and skin usually covers the defect. The
underlying mechanism for SBO is not exactly clear, but accumulating
evidence suggests that SBO is caused primarily by defects in the so-
matic mesoderm surrounding the neural tube rather than the neuralprotein on sections from control (A) and Tgfbr2cko (B) embryos at E15.5 days. Positive
wn in (C). c: cartilage, drg: dorsal root ganglion, Magniﬁcation: 40×. (D–H) In situ hy-
ot ganglion (E, G). (I–K) In situ hybridization to PdgfcmRNA in control (I) and Tgfbr2cko
. Hybridization to a labelled sense probe is used as the negative control (H, K).
Fig. 5. Proposed model for the role of Tgfbr2 in development of the spinous process.We
propose the following model for TGFβ action in the development of the spinous pro-
cess. In wild type embryos (left), TGFβ acts on its receptor in cartilage derived from
sclerotome to stimulate PDGF ligand expression. PDGF ligands are then secreted and
bind to PDGFRα on the adjacentmesenchyme. This paracrine activation of PDGF signaling
promotes proliferation andmigration of these cells eventually leading to the closure of the
neural arches and formation of the spinous process. In Tgfbr2cko embryos (right), PDGF li-
gands are not made in sufﬁcient amount to stimulate proliferation and migration of the
adjacent mesenchyme. Alterations in the adjacent mesenchyme lead to failure in the for-
mation of the spinous process.
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2008; Stottmann et al., 2006).
In this study, we demonstrated that mice with conditional deletion
of Tgfbr2 have defects in formation of the dorsal vertebrae grossly ev-
ident around E16.5 days. In addition, the layer of mesenchyme adja-
cent to the cartilage was reduced. We used a transwell-type
chemotaxis assay to show that TGFβ regulates migration of sclero-
tome associated mesenchyme in culture and we proposed that the
failure of the neural arches to close in the Tgfbr2 mutant embryos
could be due to defects in proliferation and migration of these cells
in vivo. Mice with mutations in Pdgfra have overlapping phenotypes
speciﬁcally in the spinous process similar to the Tgfbr2cko mice de-
scribed here (Pickett et al., 2008). A broad deletion of Pdgfrα in con-
densed mesenchyme showed signiﬁcantly affected vertebral
development, in which the spinous process was absent in the lumbar
region. Unlike mice deleted for Tgfbr2, vertebral bodies, vertebral
arches, and pedicles developed normally. It was suggested that loss
of PDGF signaling in the mesenchyme adjacent to the sclerotome led
to failure of the neural arches to close since deletion of Pdgfrα from
the sclerotome itself using Col2a-Cre mediated recombination did
not affect vertebral development (Payne et al., 1997; Pickett et al.,
2008). This may have been expected since PDGFRα is not expressed
in the sclerotome but is expressed in the adjacent mesenchyme
(Pickett et al., 2008). Likewise, we showed that PDGF-B and -C are
expressed in sclerotome-derived cartilage and PDGFRβ (not shown)
is predominantly expressed in the adjacent mesenchyme. Further-
more, immunohistochemical staining of PDGF-B and in situ hybridiza-
tion of Pdgfb and Pdgfc in Tgfbr2cko embryos suggested restricted
expression in cartilage in agreement with decreased expression seen
in Tgfbr2cko cells in culture. Since PDGF-B and PDGF-C can bind
PDGFRα (Bornfeldt et al., 1995), they could act as a link between
TGFβ signaling in the cartilage and PDGFRα signaling in the adjacent
mesenchyme to regulate formation of the spinous process.
It has been shown that TGFβ induces Pdgfb transcription at least
partially through Smad family members (Taylor and Khachigian,
2000). Consistent with these results, we showed that Pdgfb and Pdgfc
are downstream targets of TGFβ and PDGF-BB promotes cell migra-
tion. Furthermore, blockade of the PDGF signaling pathway by the
drug AG1296 disrupted TGFβ-induced migration of cells in culture,
while exogenous PDGF-BB restored the migration capability of cells
lacking Tgfbr2. These results suggest that PDGF signalling is required
for TGFβ-induced migration; however, loss of Pdgfb function in mice
leads to a phenotype dramatically unrelated to the phenotype result-
ing from loss of Pdgfrα (Leveen et al., 1994). Previous characterization
of mice with targeted deletion of Pdgfc demonstrated failure of the
neural arches to close in the lower spine, similar to what is seen in
the Pdgfra deleted mice (Ding et al., 2004). It was suggested that
PDGF-C acts through PDGFRα to mediate this phenotype. Together
the results suggest that failure of the neural arch closure in Tgfbr2cko
mice is likely due to TGFβmediated regulation of Pdgfc expression al-
though we cannot rule out an effect due to the other PDGF ligands.
Based on these observations, we propose a model in which TGFβ sig-
naling in the sclerotome-derived cartilage regulates the closure of the
neural arches (Fig. 5): ﬁrst, TGFβ stimulates PDGF ligand expression in
sclerotome derived cells. PDGF ligands then act in a paracrine manner
to stimulate PDGFRα on the adjacent mesenchymal cells. Activation of
PDGF signaling promotes proliferation and migration of these cells.
It was previously shown that the PDGFRα responding mesen-
chyme secretes an unknown chondrogenic factor (Pickett et al.,
2008). Expression of the chondrogenic factor was not dependent on
PDGF; however, it would be predicted that the presence and proper
location of themesenchyme adjacent to the sclerotomewould be nec-
essary to direct the chondrogenic activity to the correct location at the
dorsal tip of the developing neural arch and spinous process. BMPs
have been found to be expressed in the dorsal part of the embryo at
the time the spinous process is forming, and the effects of BMP onpromoting the dorsal closure of vertebrae were demonstrated using
grafts with BMP4-producing cells in chick embryos (Monsoro-Burq
et al., 1996). It is possible that loss of Tgfbr2 disrupts chondrogenesis
in the spinous process because of a reduction in the mesenchyme ad-
jacent to the forming cartilage and subsequentmislocalization of BMP.
Based on our observations, we conclude that TGFβ signaling is re-
quired for closure of the neural arches and formation of the spinous
process. This action is likely mediated by PDGF ligands and its para-
crine role in regulating proliferation and migration of the adjacent
mesenchyme. Our study is the ﬁrst to analyze the mechanism of ac-
tion of TGFβ signaling on development of the axial skeleton, and to
show that PDGF is an important mediator in TGFβ-induced migration
associated with skeletal development.
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